Alaska Air Group Inc.
Rating
Updated: Aug 24, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Alaska Air Group, Inc. operates via its subsidiaries, providing comprehensive air transportation solutions for both passengers and freight. Its business is organized into three principal segments: Mai...
Latest News
6 days ago · zacks.com
Alaska Air Group (ALK) Declines More Than Market: Some Information for InvestorsAlaska Air Group (ALK) concluded the recent trading session at $40.71, signifying a -1.09% move from its prior day's close.
7 days ago · globenewswire.com
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study-- Topline Phase 1 data shows generally favorable safety and tolerability profile of AGMB-447 -- -- Pharmacokinetic profile confirms efficient lung restriction with low systemic exposure and high exposure of AGMB-447 in the lung, in line with prior results observed in healthy participants -- -- Robust target engagement of ALK5 observed with AGMB-447 in IPF patients -- -- Clinical Trial Application (CTA) for INSPIRIA Phase 2 study in IPF patients submitted; Company intends to initiate study before year-end -- Antwerp, Belgium, September 14, 2026 – Agomab Therapeutics NV (‘Agomab'), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced positive results of the Phase 1 study of AGMB-447 in IPF patients. AGMB-447 is an investigational inhaled lung-restricted small molecule inhibitor of ALK5 (or TGFβR1) intended for the treatment of Idiopathic Pulmonary Fibrosis (IPF).1 The Phase 1 study of AGMB-447 is a three-part, double-blind, randomized, placebo-controlled single ascending dose (SAD; Part A; dose range: 1 mg QD (once daily) to 20 mg QD) and multiple ascending dose (MAD; Part B; dose range: 1 mg QD to 6 mg BID (twice daily)) study in healthy participants and multiple dose study in IPF patients (Part C; dose range: 4.5 mg BID to 6 mg BID).
10 days ago · globenewswire.com
ALK to present at the Morgan Stanley Global Healthcare Conference in New YorkALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the company's Executive Vice President and CFO, Claus Steensen Sølje, is scheduled to participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City taking place from 14 - 16 September 2026 on Monday, 14 September 2026, at 3.20 PM EDT.
10 days ago · defenseworld.net
Hsbc Holdings PLC Has $3.39 Million Stake in Alaska Air Group, Inc. $ALKHsbc Holdings PLC lowered its stake in Alaska Air Group, Inc. (NYSE: ALK) by 65.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 65,242 shares of the transportation company's stock after selling 122,254 shares during the quarter. Hsbc Holdings PLC
11 days ago · globenewswire.com
Group Resources & Reserves Statement FY26PERTH, Australia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (‘Alkane' or ‘the Company') is pleased to summarise the latest update to the Mineral Resource and Ore Reserve estimates for its assets in Australia and Sweden as at 30 June 2026.
12 days ago · zacks.com
Alaska Airlines Expands San Diego Network With 50th Nonstop RouteALK expands in San Diego with seasonal nonstop service to Loreto, its 50th destination, while investing in loyalty and passenger experience.
13 days ago · zacks.com
Here's Why Alaska Air Group (ALK) Fell More Than Broader MarketIn the closing of the recent trading day, Alaska Air Group (ALK) stood at $40.74, denoting a -3.09% move from the preceding trading day.
29 days ago · globenewswire.com
New High-Grade Domain Discovered at CuffleyPERTH, Australia, Aug. 23, 2026 (GLOBE NEWSWIRE) -- Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (‘Alkane' or ‘the Company') is pleased to announce the latest exploration results highlighting the discovery of a new high-grade zone of the Cuffley Lode, and drilling results from the Sub-KC domain at depth below the Augusta mine and the Costerfield property in Victoria, Australia Program Summary 23 new holes have been drilled in an unmined area between the historical Cuffley north and south high-grade grade panels, and 17 additional holes have targeted the Sub KC domain at depth below the deposit A new grade pod with areas of very high grade gold and antimony was identified in the Cuffley infill area, in a sparsely drilled zone previously thought to contain low grade due to the influence of a crosscutting fault Additional high grade infill intercepts have made in the Sub KC system, and the first target testing holes looking for repetitions of the structural setup have been drilled The Cuffley pod is readily accessible from existing infrastructure and is being incorporated into the mine schedule Assay Highlights From Cuffley 580.9g/t gold and 24% antimony over 0.61m (ETW 0.54m) in AD270 168.9g/t gold and 33.5% antimony over 0.9m (ETW 0.78m) in AD265 60.1g/t gold and 15.2% antimony over 1.26m (ETW 1.17m) in AD292 124g/t gold and 48.6% antimony over 0.23m (ETW 0.22m) in AD275 From Sub KC 28.2g/t gold and 0% antimony over 0.99m (ETW 0.82m) in CSK044 73.2g/t gold and 18.8% antimony over 0.19m (ETW 0.18m) in CSK043 192g/t gold and 0% antimony over 0.17m (ETW 0.07m) in CSK043 16.1g/t gold and 12.7% antimony over 0.37m (ETW 0.34m) in CSK048 Alkane Managing Director & CEO, Nic Earner, said: “This discovery of unmined high-grade material directly adjacent one of Costerfield's top-shelf historical orebodies showcases the importance of Alkane's directive of revisiting and challenging old models and preconceptions surrounding mineralisation to extract value. We will continue seeking this new mineralisation alongside generating new targets within our leases.
29 days ago · globenewswire.com
Appointment of Non-Executive DirectorsPERTH, Australia, Aug. 23, 2026 (GLOBE NEWSWIRE) -- Alkane Resources Limited (ASX: ALK, TSX: ALK, OTCQX: ALKRY) (‘Alkane') is pleased to announce the appointments of Dr Jennifer Purdie and The Hon. Gabrielle Upton to the Alkane Board as independent Non-Executive Directors, with effect from today, 24 August 2026.
1 month ago · fool.com
Alaska Air's CEO Buys 25,000 Shares Amid a 28% Decline in the Stock Price. Here's a Deeper Look at the Transaction.CEO Benito Minicucci acquired 25,000 shares at a weighted average price of $40.06 per share, representing a total investment of ~$1 million. The transaction increased the executive's direct equity position by 11%.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ALK